On March 31, Health & Human Services Secretary Alex Azar announced the creation of a new FDA program, the Coronavirus Treatment Acceleration Program (“CTAP”), designed to speed up the development of life-saving treatments that have the potential to be both safe and effective, observed Arent Fox in its FDA COVID-19 enewsletter. Secretary Azar presented this new program as a new public-private cooperation that would involve redeploying medical and regulatory staff, including those from CDE...